Speakers - Advanced Therapies Week

Aaron Solis

Director, Business Development • AGC Biologics

Aditi Singh

Global Senior Marketing Manager • Sony Biotechnology Inc

Allen Fang

Co-Founder and Chief Scientific Officer • HebeCell Corp

Amritha Jaishankar

Executive Director • Maryland Stem Cell Research Fund

Andrea Zobel

Senior Director, Personalized Supply Chain • AmerisourceBergen

Angela Justice

Chief People Officer • TCR2 Therapeutics

Anirban Ghosh

Director, Supply Chain Business Systems Architect • Genentech

Anthony Renodon

Business Development Officer • TreeFrog Therapeutics

Anthony Ting

Chief Scientific Officer • Bone Therapeutics

Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

Barbara A. Binzak Blumenfeld

Shareholder, FDA & Biotechnology • Buchanan Ingersoll Rooney

Becky Cap

Chief Operating Officer, GenCure, Senior Vice President • BioBridge Global

Blair Clark-Schoeb

Senior Vice President, Communications • Aruvant

Brian Feth

Co-Founder and Chief Executive Officer • Xcellbio

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania

Bruce Thompson

Technical Head of Cell Therapy • Resilience

Bryan Poltilove

Operational Partner • Broadoak Capital Partners

Carmen Brenner

Director, Manufacturing Sciences and Technologies (MSaT) • Novadip

Carol Houts

Vice President, Quality and Business Strategy • Germfree

Cate Dyer

Chief Executive Officer & Founder • StemExpress, LLC

Cedric Ait Mansour

Global Senior Manager Market Development – New Products • Sony Biotechnology Inc

Cenk Sumen

Chief Technology Officer • Stemson Therapeutics

Chris Wegener

Director, Cell Therapy R&D • Fresenius Kabi

Christopher Ballas

Senior Vice President, Manufacturing • Innovative Cellular Therapeutics

Clark Paramore

Head of Value Demonstration, Vice President of HEOR • bluebird bio

Craig Shepherd

Senior Managing Director • Blackstone Life Sciences

Dan Gincel

Senior Vice President, Strategic Collaborations & Scientific Affairs • Longeveron

Daniel C. Smith

Executive Director, Global Cell & Gene Therapy Portfolio • Charles River

Daniel Teasley

Head of Viral & Gene Therapy Products and Services • MilliporeSigma

David Fontana

Chief Business and Strategy Officer • Umoja Biopharma

David Pearce

President of Innovation, Research & World Clinic • Sanford Health

David Peritt

Founder & Chief Scientific Officer • Lupagen

David Sheehan

Founder and Chief Executive Officer • Nucleus Biologics

Dawn Henke

Senior Technical Program Manager • Standards Coordinating Body

Delara Motlagh

General Manager, Cell Therapy Technologies • Terumo Blood and Cell Technologies

Dhvanit Shah

Founder, President and Chief Executive Officer • Garuda Therapeutics

Diego Correa

Director, Medical Strategy Lead, Cell & Gene Therapy Center of Excellence • IQVIA

Dominic Clarke

Chief Technology Officer • Discovery Life Sciences

Donna Rill

Chief Technology Officer • Triumvira Immunologics

Dr Raymond Stapleton

Executive Vice President, Pharmaceutical Services and Manufacturing • Genocea

Dragan Djordjevic

Associate Director, Cell Therapy Robotics, Data Automation and Machine Learning • Takeda

Edita Botonjic-Sehic

Director of Analytics, Digital Innovation • Pall Corporation

Emily Benz

Engineer II, Process Development • ViaCyte

Emily English

Director of Quality • Cartesian Therapeutics

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

Emma Cheesman

Director of Development Consulting and Scientific Affairs • BioPharma Excellence

Erwin Cammaart

Executive Director, Process Development • Iovance Biotherapeutics Inc

Eugene Brandon

Head, Cell & Gene Therapy Translation • IQVIA

Evan Zynda

Staff Scientist • Thermo Fisher Scientific Inc

Fabian Gerlinghaus

Co-Founder and Chief Executive Officer • Cellares

Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda

Farzin Farzaneh

Chief Scientific Officer & Co-Founder • ViroCell Biologics

Gabriella Perell

Cell and Gene Therapy Product Manager • Bio-Techne

Garrie Richardson

General Manager, SciSafe • BioLife Solutions

George Buchman

Vice President, Preclinical Service and Process Development • Catalent Cell and Gene Therapy

George Smith

Vice President, Cell Therapy Operations • Turnstone Bio

Géraldine Guérin-Peyrou

Director of Marketing and Scientific Support • Polyplus-Transfection

Gerry Farrell

Chief Operating Officer • Fujifilm Diosynth Biotechnologies

Haro Hartounian

Senior Vice President and General Manager • BioCentriq

Ian Goodwin

Associate Director, Global Program Design • Fujifilm Diosynth Biotechnologies

Ivan Wall

Director, Advanced Therapies Manufacturing National Training Centre and Co-Founder & Director of FourPlus Immersive • FourPlus Immersive

J Kelly Ganjei

President and Chief Executive Officer • AmplifyBio

Jacob Becraft

Chief Executive Officer • Strand Therapeutics

James Wang

Chief Technology Officer • Juventas Cell Therapy

Janet Lynch Lambert

Chief Executive Officer • Alliance for Regenerative Medicine

Jeff Boyd

Partner and Life Sciences Tools & Services Sector Co-Leader • Heidrick & Struggles

Jeff Buck

Vice President, Business Optimization Lash Group • AmerisourceBergen

Jeff Liter

Chief Executive Officer • Luminary Therapeutics

Jenessa Smith

Associate Director of Process Development • Arsenal Bio

Jo Anne Valentino

Chief Operating Officer • Minaris Regenerative Medicine

Joachim Fruebis

Chief Development Officer • BlueRock Therapeutics

John Kerwin

Technical Head of Gene Therapy Franchise • Resilience

edical Director of Transfusion Medicine at Boston Children, Associated Faculty Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Associate Professor of Pathology Harvard Medical School • Harvard Medical School

John Maslowski

Chief Commercial Officer • Forge Biologics

John Moscariello

Executive Director, Viral Vector & Gene Editing Process Development • Bristol Myer Squibb

John Schick

Vice President, Global Market Access and Policy • Instil Bio

Jon Ellis

Manager • Invetech

Joseph (Yossi) Schwartz

Medical Director, Transfusion Medicine Quality Assurance • Mount Sinai Health System

Joseph Garrity

Director, Commercial Development (CGT), Autologous Cell Therapy • Lonza Ltd

Joseph Micsko

Global Director, Process Manufacturing Technology • CAI

Josh Ludwig

Global Director, Commercial Operations • ScaleReady

Joy Aho

Senior Product Manager • Be The Match BioTherapies

Judith Koliwer

Principal Consultant, Cell and Gene Therapy • Körber

Julia Tarasenko

VP, Commercial Operations, EMEA and Americas • Marken

Katy Spink

Chief Operating Officer & Managing Partner • Dark Horse Consulting

Kei Kishimoto

Chief Scientific Officer • Selecta Bio

Ken Rando

Business Development Manager • Comecer S.p.A

Kent Christopherson

Senior Director, Medical Affairs • Orchard Therapeutics

Kent Thorup

Regional Vice President of Business Development • QuickSTAT Global Life Science Logistics

Kevin Ramdas

Director, Medical Affairs • Longeveron

Kim Raineri

Chief Manufacturing and Technology Officer • AVROBIO

Kimberly Negrin

Director, Cell Therapy Strategy and Business Operations • Charles River

Krishendu Roy

Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT) • Georgia Tech

Krishnan Viswanadhan

President and Chief Operating Officer • Be Biopharma

Kurt Swogger

Kwok Pang

Chief Operating Officer and Co-Founder • Autolomous

Lauren Shelton

Laurent Humeau

Chief Science Officer • INOVIO

Lavakumar Karyampudi

Technical Director, Cell Therapy Facility • Moffitt Cancer Center

Leisha Kopp

Applications Scientist • Mirus Bio

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron

Lisa Ward

• Emily Whitehead Foundation

Lizette Caballero

Regional CAR T Site Liaision • Janssen

Louis Walcer

Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences • Cornell University

Lucas De Breed

Founder and Managing Director • August Care

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Mamta Kalra

Director, Department of Chemistry, Manufacture and Control (CMC) • Immatics

Marco Fadda

ATMP Solutions Manager • Comecer S.p.A

Mari Mitrani

Chief Science Officer • Organicell Regenerative Medicine

Maria Croyle

Professor of Molecular Pharmaceutics and Drug Delivery/Glaxo Wellcome Professor • University of Texas at Austin

Mark Sawicki

Chief Executive Officer • Cryoport Systems

Mark Throsby

Chief Scientific Officer • Gadeta

Mathias Svahn

Chief Executive Officer • NextCell Pharma

Matthew Hewitt

Senior Director, Scientific Services, Cell and Gene Therapy • Charles River

Matthew Lakelin

Vice President, Business Development and Scientific Affairs • TrakCel

Matthew Li

Associate Director, Head of Cell Therapy Manufacturing Innovation • Vor Biopharma

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings • American Red Cross

Metin Kurtoglu

Chief GMP Manufacturing Officer • Cartesian Therapeutics

Michael Blackton

Sr. Vice President, Cell Therapy Manufacturing, DeTIL Development • Nurix Therapeutics

Michael Griffin

Product Manager, Global Commercial Development • Cook MyoSite

Michael Leek

Executive Chairman • TC BioPharm

Michael Lehmicke

Senior Director, Science and Industry Affairs • Alliance for Regenerative Medicine

Michael Mercaldi

Senior Director, Downstream Process Development • Homology Medicines

Michael Paglia

Chief Operating Officer • Elevate Bio

Michael Titus

Vice President of Quality and Operations • AVOBIS BIO

Miguel Dominguez

Director of Sales and Support • Mirus Bio

Miguel Forte

Chief Executive Officer • Bone Therapeutics

Mike Orrico

Treasurer and Executive Committee • Standards Coordinating Body

Nathalie Clement

Associate Program Director & Associate Professor • Powell Gene Therapy Center

Nathan Moore

Associate Director, Manufacturing Technologies, Cell Therapies • Takeda

Nathan Moore

Associate Director, Engineering & Automation, Cell Therapies • Takeda

Nicholas Ostrout

Senior Director, Commercial Strategy and Implementation • Lonza Ltd

Nina Bauer

Senior Director, Head of Commercial, Gene Therapy • MilliporeSigma

Ohad Karnieli

Founder & CEO • Adva Biotechnology

Øystein Åmellem

Director, Cell Bio • Thermo Fisher Scientific Inc

Patrick Lucy

Chief Executive Officer • Lykan Bioscience

Patrick Westmoreland

Principal Scientist, Viral Vector and Gene Editing Process Development • Bristol Myer Squibb

Paul Kosnik

Vice President, Clinical Development • Orgenesis

Peter Danforth

Business Development Manager • Wacker Chemie

Peter Marks

Director of the Center for Biologics Evaluation and Research • FDA

Peter Olagunju

Chief Technology Officer • TCR2 Therapeutics

Peter Walters

Director, Advanced Therapies • CRB

Phil Morton

Chief Technology Officer • Albumedix

Pierre Axel Vinot

Associate Director, CMC Portfolio Management • Sparing Vision

Pinar Cicalese

Director, CMC Commercial Strategy • Immatics

Qian Hao

Chief Technology Officer • Porton Advanced

Rachel Legmann

Director of Technology, Gene Therapy • Repligen

Radmila Feldmann

Patient-Centric Supply Chain Solutions for Cell and Gene Therapies • Time:Matters

Rhessa Diaz

Senior Manager of Cell Therapy Analysis • Bristol Myer Squibb

Richard McFarland

Chief Regulatory Officer • ARMI

Robert Lechich

Principal Consultant • Global OT/IT Quality Services

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific

Robert Speziale

Ryan Cawood

Chief Scientific Officer • WuXi Advanced Therapies

Ryan Pruchnic

Managing Vice President • Cook MyoSite

Sadaf Naz Khan

Regional CAR T Site Liaision • Janssen

Sadik Kassim

Chief Technology Officer • Vor Biopharma

Samik Basu

Chief Scientific Officer • Cabaletta Bio

Sander Van Deventer

Chief Scientific Officer • Porton Advanced

Sarah Thomas

Vice President of Quality • REGENXBIO

Sean Werner

President • Sexton Biotechnologies

Shannon Eaker

Cell and Gene Therapy Enterprise Technical Leader • Cytiva

Sharon Brownlow

Chief Business Officer • Cell and Gene Therapy Catapult

Shepherd Mpofu

Chief Medical Officer • Novartis Gene Therapies

Shyam Patal

Director of Business Development • CIRM

Stefanos Theoharis

Chief Business Officer • Bone Therapeutics

Susan Nichols

President and Chief Executive Officer • Propel Biosciences

Sven Kili

Chief Executive Officer • Antion

Tamer Mohamed

President & Chief Executive Officer • Aspect Biosystems

Tamer Mohamed

President & Chief Executive Officer • Aspect Biosystems

Tania D. Pereira Chilima

Chief Technology Officer • Univercells Technologies

Tara Crnkovich

Senior Director, Site Lead – Clinical Biologics & Cell Therapy Manufacturing • AstraZeneca

Thomas Bollenbach

Chief Technology Officer • ARMI

Tiffany Rau

Owner and Principal Consultant • Rau Consulting

Tim Farries

Principal Consultant, Senior Director • BioPharma Excellence

Timothy Schroeder

Chairman, Chief Executive Officer and Founder • CTI

Todd Sulchek

Co-Founder • CellFe

Tom Whitehead

Founder • Emily Whitehead Foundation

Tony Ward

Chief Technology Officer • GPB Scientific, LLC

Trent Carrier

Chief Operating Officer • L7 Informatics

Vasu Rangadass

President & Chief Executive Officer • L7 Informatics

Whitney Ijem

Senior Vice President, Strategy & Business Development • Krystal Biotech

Will Chou

Chief Executive Officer • Aruvant

Yina Santiago-Rodriguez

Process Development Manager • Fujifilm Cellular Dynamics

2022 Speakers